Ken Griffin’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-29,192
| Closed | -$67.1K | – | 15390 |
|
|
2026
Q2 | $67.1K | Buy |
+29,192
| New | +$70.6K | ﹤0.01% | 12963 |
|
|
2025
Q4 | – | Sell |
-42,816
| Closed | -$106K | – | 14260 |
|
|
2025
Q3 | $114K | Buy |
42,816
+10,333
| +32% | +$30.6K | ﹤0.01% | 11753 |
|
|
2025
Q2 | $96.5K | Buy |
+32,483
| New | +$94.4K | ﹤0.01% | 11382 |
|
|
2025
Q1 | – | Sell |
-13
| Closed | -$51 | – | 15709 |
|
|
2024
Q4 | $51 | Buy |
+13
| New | +$89 | ﹤0.01% | 14391 |
|
|
2024
Q3 | – | Sell |
-4,890
| Closed | -$25.1K | – | 15379 |
|
|
2024
Q2 | $25.1K | Sell |
4,890
-2,152
| -31% | -$16.6K | ﹤0.01% | 12434 |
|
|
2024
Q1 | $57.3K | Sell |
7,042
-5,232
| -43% | -$30K | ﹤0.01% | 12045 |
|
|
2023
Q4 | $49.1K | Buy |
12,274
+1,621
| +15% | +$6.46K | ﹤0.01% | 11796 |
|
|
2023
Q3 | $43.9K | Sell |
10,653
-5,946
| -36% | -$29.8K | ﹤0.01% | 11899 |
|
|
2023
Q2 | $98.6K | Sell |
16,599
-3,775
| -19% | -$17K | ﹤0.01% | 10964 |
|
|
2023
Q1 | $70.3K | Buy |
20,374
+8,649
| +74% | +$32.2K | ﹤0.01% | 11725 |
|
|
2022
Q4 | $41.2K | Buy |
+11,725
| New | +$40K | ﹤0.01% | 12376 |
|
|
2022
Q3 | – | Sell |
-80,884
| Closed | -$455K | – | 13734 |
|
|
2022
Q2 | $455K | Buy |
80,884
+39,615
| +96% | +$267K | ﹤0.01% | 8855 |
|
|
2022
Q1 | $356K | Buy |
+41,269
| New | +$414K | ﹤0.01% | 10189 |
|
|
2021
Q4 | – | Sell |
-47,828
| Closed | -$619K | – | 14881 |
|
|
2021
Q3 | $619K | Buy |
+47,828
| New | +$762K | ﹤0.01% | 9358 |
|
|
2020
Q4 | – | Sell |
-11,467
| Closed | -$211K | – | 11605 |
|
|
2020
Q3 | $219K | Buy |
+11,467
| New | +$198K | ﹤0.01% | 8667 |
|
|
2020
Q2 | – | Sell |
-34,134
| Closed | -$363K | – | 10609 |
|
|
2020
Q1 | $363K | Buy |
+34,134
| New | +$556K | ﹤0.01% | 6990 |
|
|
2019
Q3 | – | Sell |
-19,227
| Closed | -$146K | – | 9829 |
|
|
2019
Q2 | $146K | Buy |
+19,227
| New | +$167K | ﹤0.01% | 8371 |
|
|
2017
Q3 | – | Sell |
-19,661
| Closed | -$92.8K | – | 8130 |
|
|
2017
Q2 | $92K | Buy |
+19,661
| New | +$188K | ﹤0.01% | 6939 |
|
Other funds holding XBIT
Ken Griffin's XBIT Position: Q3 2026 in Review
Ken Griffin sold out of XBiotech (XBIT) in Q3 2026, closing a stake of 29,192 shares — an estimated $67.1K sold.
Ken Griffin first reported a position in XBIT in Q2 2017 and held it in 18 quarters. The position peaked at $619K in Q3 2021. 34 funds tracked by Wall St. Rank hold XBIT as of Q3 2026.
- Ken Griffin reported no remaining XBiotech position as of Q3 2026 after selling out during the quarter.
- Ken Griffin sold 29,192 XBiotech shares in Q3 2026, an estimated $67.1K.
- Ken Griffin first reported a position in XBiotech in Q2 2017 and held it in 18 quarters.
- Ken Griffin's XBiotech position peaked at $619K in Q3 2021.
- 34 funds tracked by Wall St. Rank held XBiotech as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.